MYC expression and distribution in normal mature lymphoid cells

Journal of Pathology

Volumn 229, Issue 3, 2013, Pages 430-440

  Cattoretti, Giorgio ^a,b  

^a AO San Gerardo ^*  (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

B cell; germinal centre transit; mantle zone; marginal zone; MYC

Indexed keywords

CD30 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INTERFERON REGULATORY FACTOR 4;

ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOID CELL; MEMORY CELL; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL;

B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL LINE; FLOW CYTOMETRY; GERMINAL CENTER; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; PALATINE TONSIL; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84872975631     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4141     Document Type: Article

References (56)

1. Dalla-Favera R, Gelmann EP, Martinotti S, et al,. Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). Proc Natl Acad Sci U S A 1982; 79: 6497-6501. (Pubitemid 13207522)
2. Meyer N, Penn LZ,. Reflecting on 25 years with MYC. Nature Rev Cancer 2008; 8: 976-990.
3. Dang CV,. Links between metabolism and cancer. Genes Dev 2012; 26: 877-890.
4. Littlewood TD, Kreuzaler P, Evan GI,. All things to all people. Cell 2012; 151: 11-13.
5. Grandori C, Cowley SM, James LP, et al,. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000; 16: 653-699. (Pubitemid 32037520)
6. Perez-Roger I, Solomon DL, Sewing A, et al,. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 1997; 14: 2373-2381. (Pubitemid 27268156)
7. Dominguez-Sola D, Ying CY, Grandori C, et al,. Non-transcriptional control of DNA replication by c-Myc. Nature 2007; 448: 445-451. (Pubitemid 47123512)
8. Dang CV,. MYC on the path to cancer. Cell 2012; 149: 22-35.
9. Reed JC, Alpers JD, Nowell PC,. Expression of c-myc proto-oncogene in normal human lymphocytes. Regulation by transcriptional and posttranscriptional mechanisms. J Clin Invest 1987; 80: 101-106. (Pubitemid 17097522)
10. Klein U, Tu Y, Stolovitzky GA, et al,. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci U S A 2003; 100: 2639-2644. (Pubitemid 36297551)
11. Martinez-Valdez H, Guret C, de Bouteiller O, et al,. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 1996; 183: 971-977.
12. Rabbitts PH, Watson JE, Lamond A, et al,. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J 1985; 4: 2009-2015.
13. Waters CM, Littlewood T, Hancock DC, et al,. c-myc protein expression in untransformed fibroblasts. Oncogene 1991; 6: 797-805. (Pubitemid 21924153)
14. Vervoorts J, Lüscher-Firzlaff J, Lüscher B,. The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 2006; 281: 34725-34729. (Pubitemid 46036511)
15. Wang K, Saito M, Bisikirska BC, et al. Genome-wide identification of post-translational modulators of transcription factor activity in human B cells. Nature Biotechnol 2009; 27: 829-837.
16. Chung EY, Psathas JN, Yu D, et al,. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. J Clin Invest 2012; 122: 2257-2266.
17. Kastan MB, Stone KD, Civin CI,. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells. Blood 1989; 74: 1517-1524. (Pubitemid 19251523)
18. Cutrona G, Dono M, Pastorino S, et al,. The propensity to apoptosis of centrocytes and centroblasts correlates with elevated levels of intracellular myc protein. Eur J Immunol 1997; 27: 234-238. (Pubitemid 27046083)
19. Abrams HD, Rohrschneider LR, Eisenman RN,. Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell 1982; 29: 427-439.
20. Mitani S, Sugawara I, Shiku H, et al,. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques. Cancer 1988; 62: 2085-2093. (Pubitemid 18261842)
21. Green TM, Nielsen O, de Stricker K, et al,. High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma. Am J Surg Pathol 2012; 36: 612-619.
22. Jack AS, Kerr IB, Evan GI, et al,. The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry. Br J Cancer 1986; 53: 713-719. (Pubitemid 16082025)
23. Loke SL, Neckers LM, Schwab G, et al,. c-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution. Am J Pathol 1988; 131: 29-37.
24. Ruzinova MB, Caron T, Rodig SJ,. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation. Am J Surg Pathol 2010; 34: 882-891.
25. Wu KJ, Polack A, Dalla-Favera R,. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 1999; 283: 676-679.
26. Cattoretti G, Shaknovich R, Smith PM, et al,. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J Immunol 2006; 177: 6930-6939. (Pubitemid 44715059)
27. Cattoretti G, Büttner M, Shaknovich R, et al,. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 2006; 107: 3967-3975. (Pubitemid 43726803)
28. Gurel B, Iwata T, Koh CM, et al,. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 2008; 21: 1156-1167.
29. Pasqualucci L, Bhagat G, Jankovic M, et al,. AID is required for germinal center-derived lymphomagenesis. Nature Genet 2008; 40: 108-112.
30. Lebecque S, de Bouteiller O, Arpin C, et al,. Germinal center founder cells display propensity for apoptosis before onset of somatic mutation. J Exp Med 1997; 185: 563-571. (Pubitemid 27078374)
31. Ho WY, Cooke MP, Goodnow CC, et al,. Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med 1994; 179: 1539-1549. (Pubitemid 24129571)
32. Falini B, Tiacci E, Pucciarini A, et al,. Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 2003; 102: 3684-3692. (Pubitemid 37409389)
33. Cattoretti G, Angelin-Duclos C, Shaknovich R, et al,. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J Pathol 2005; 206: 76-86. (Pubitemid 40613437)
34. Thompson CB, Challoner PB, Neiman PE, et al,. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 1985; 314: 363-366. (Pubitemid 15122117)
35. Hann SR, Thompson CB, Eisenman RN,. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 1985; 314: 366-369. (Pubitemid 15122118)
36. Schuhmacher M, Staege MS, Pajic A, et al,. Control of cell growth by c-Myc in the absence of cell division. Curr Biol 1999; 9: 1255-1258. (Pubitemid 29527152)
37. Lin YC, Wong KK, Calame KL,. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997; 276: 596-599.
38. Evan GI, Lewis GK, Ramsay G, et al,. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 1985; 5: 3610-3616. (Pubitemid 16233068)
39. Wagner S, Amen F, Trivedi P, et al,. Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma. Leuk Lymphoma 2007; 48: 1510-1513. (Pubitemid 47272800)
40. Eisenman RN,. Deconstructing myc. Genes Dev 2001; 15: 2023-2030. (Pubitemid 32762045)
41. Kerfoot SM, Yaari G, Patel JR, et al,. Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone. Immunity 2011; 34: 947-960.
42. Kitano M, Moriyama S, Ando Y, et al,. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 2011; 34: 961-972.
43. Glynne RJ, Akkaraju S, Healy JI, et al,. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 2000; 403: 672-676. (Pubitemid 30104010)
44. Hauser AE, Junt T, Mempel TR, et al,. Definition of germinal-center B cell migration in vivo reveals predominant intrazonal circulation patterns. Immunity 2007; 26: 655-667. (Pubitemid 46756352)
45. Calado DP, Sasaki Y, Godinho SA, et al,. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. Nature Immunol 2012; 13: 1092-1100
46. Dominguez-Sola D, Victora GD, Ying CY, et al,. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nature Immunol 2012; 13: 1083-1091.
47. Kraus M, Alimzhanov MB, Rajewsky N, et al,. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004; 117: 787-800. (Pubitemid 38748894)
48. Ci W, Polo JM, Cerchietti L, et al,. The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. Blood 2009; 113: 5536-5548.
49. Meyer-Bahlburg A, Bandaranayake AD, Andrews SF, et al,. Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J Immunol 2009; 182: 4065-4075.
50. Murphy MJ, Wilson A, Trumpp A,. More than just proliferation: Myc function in stem cells. Trends Cell Biol 2005; 15: 128-137. (Pubitemid 40332535)
51. Reavie L, Della Gatta G, Crusio K, et al,. Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex. Nature Immunol 2010; 11: 207-215.
52. Watt FM, Frye M, Benitah SA,. MYC in mammalian epidermis: how can an oncogene stimulate differentiation? Nature Rev Cancer 2008; 8: 234-242. (Pubitemid 351301841)
53. Wilson A, Murphy MJ, Oskarsson T, et al,. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004; 18: 2747-2763. (Pubitemid 39507768)
54. Sommer A, Bousset K, Kremmer E, et al,. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J Biol Chem 1998; 273: 6632-6642. (Pubitemid 28160320)
55. Gregory MA, Hann SR,. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 2000; 20: 2423-2435. (Pubitemid 30152050)
56. Hillman MC, Yang LS, Sun S, et al,. A comprehensive system for protein purification and biochemical analysis based on antibodies to c-myc peptide. Protein Expr Purif 2001; 23: 359-368. (Pubitemid 33037805)